Ed-tech platform TALi Digital (ASX:TD1) has scored certification from Google for its early-learning technology.

The company said the deal will act as an important catalyst for its pushes into the US market with its TALi Detect and TALi Train products, which are used in the treatment of attention deficit disorder in children.

The partnership will give TALi access to extended Google distribution channels, including G Suite for Education and Google Chromebooks which are used by more than 50 per cent of US schools.

TALi said that in order to get certification with Google, products needed to pass a “structured assessment and verification process”. The company will also be assigned a dedication partner manager.

As is often the case when ASX small caps sign partnership deals with global tech behemoths, shares in TALi got a boost this morning, with the stock rising by 20 per cent in morning trade.


The company — which used to be called Novita Healthcare but rebranded just before Christmas — had a big finish to 2019, rocketing from below 2c to a high of more than 10c.

It followed news in October that the TALi Detect program had been approved for reimbursement under the relevant CPT codes administered by the American Medical Association.

ALSO READ: Health: Good news from the US sends Novita shares up +60pc

TALi managing director Glenn Smith said that along with increased distribution and marketing opportunities, TALi would also have full integration with Google Single Sign In and Google Classroom.

“These integrations help streamline the user experience by allowing the input of teacher, class and student data directly into our platform, making the onboarding process as seamless as possible,” Smith said.